Dermatect: Non-Invasive AML-Based Skin Cancer Screening with Advanced Analysis Via Mobile App, Tested at Dharmais Hospital, Jakarta

Meitriana Nurelifah | Indonesia

Dermatect: Non-Invasive AML-Based Skin Cancer Screening with Advanced Analysis Via Mobile App, Tested at Dharmais Hospital, Jakarta

Meitriana Nurelifah

Indonesia

Detail

Dermatect is an Automated Machine Learning (AML) mobile application developed for non-invasive early screening and diagnosis of skin cancer, a disease that affects over 1.5 million people worldwide each year and causes more than 3,000 deaths annually in Indonesia. With tropical countries facing high ultraviolet exposure and limited dermatological access, delayed diagnosis and under-awareness remain critical issues. Dermatect analyzes high-resolution dermatoscopic images captured via smartphone.